Aug 13, 2026 04:15PM
Aug 13, 2026 04:15PM
Aug 4, 2026 08:50AM
Jul 22, 2026 08:40AM
Jul 21, 2026 07:05AM
Jul 21, 2026 07:05AM
Jul 7, 2026 08:55AM Akari Therapeutics adds oncology expert Patricia LoRusso to advisory board
Jul 7, 2026 08:55AM
Jun 29, 2026 08:45AM
Jun 29, 2026 08:45AM
Jun 4, 2026 09:30AM
May 28, 2026 09:17AM
May 21, 2026 05:01PM
May 21, 2026 05:01PM Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models
May 21, 2026 08:30AM
May 21, 2026 08:30AM
May 18, 2026 09:05AM
May 12, 2026 08:33AM
May 12, 2026 08:33AM
Apr 27, 2026 08:36AM
Apr 27, 2026 08:35AM Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
Apr 21, 2026 09:00AM
Apr 20, 2026 08:35AM
Apr 20, 2026 08:35AM
Apr 6, 2026 08:45AM
Apr 6, 2026 08:45AM
Mar 18, 2026 08:05AM
Mar 17, 2026 04:30PM Akari Therapeutics changes ADS ratio to maintain Nasdaq listing
Mar 17, 2026 04:30PM
Feb 26, 2026 09:10AM
Feb 26, 2026 09:10AM
Feb 23, 2026 08:50AM
Feb 23, 2026 08:50AM
Jan 9, 2026 09:00AM
Dec 30, 2025 09:15AM Akari Therapeutics outlines 2025 progress in shareholder letter
Dec 30, 2025 09:15AM
Dec 23, 2025 08:30AM
Dec 23, 2025 08:30AM
Dec 18, 2025 08:30AM
Dec 16, 2025 09:29AM
Dec 16, 2025 09:29AM
Dec 9, 2025 08:40AM Akari Therapeutics reports preclinical data for pancreatic cancer drug
Dec 9, 2025 08:40AM
Dec 4, 2025 09:00AM
Nov 18, 2025 08:35AM
Nov 18, 2025 08:35AM
Nov 18, 2025 08:35AM
Nov 18, 2025 08:35AM
Nov 10, 2025 08:32AM Akari Therapeutics reports preclinical data on novel ADC payload
Nov 10, 2025 08:30AM

1,219,140 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All